Difference between revisions of "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3) (Q11196)"
Jump to navigation
Jump to search
(Created claim: has part (P22): Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3) (Q10739), #quickstatements; #temporary_batch_1593026436546) |
(Created claim: has part (P22): Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740), #quickstatements; #temporary_batch_1593026436546) |
||
| Property / has part | |||
| + | |||
| Property / has part: Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) / rank | |||
| + | Normal rank | ||
Revision as of 19:20, 24 June 2020
Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3)
|
Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (English)
Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32. doi:10.1007/s11886-020-01292-3
0 references
0 references
0 references
